Literature DB >> 32957012

Repeated complete response with long-term control of BRAF-mutant melanoma by multiple rechallenges with dabrafenib plus trametinib.

Katsuhito Sasaki1, Yasuhiro Nakamura2, Natsuki Baba1, Yukiko Teramoto1, Akifumi Yamamoto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32957012     DOI： 10.1016/j.ejca.2020.08.012

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

1.  Successful re-challenge of dabrafenib-trametinib combination therapy in advanced BRAF V600E-mutant non-small cell lung cancer after previous cytotoxic chemotherapy, targeted therapy, and immunotherapy: a case report.

Authors:  Yaran Xue; Yaqian Ren; Bing Yan; Zhaona Li; Chun Huang
Journal:  Ann Transl Med       Date:  2022-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.